drugset / Trial / NCT00002608

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

NCT00002608

Phase 2 Completed 30 enrolled Ottawa Regional Cancer Centre
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as cisplatin and doxorubicin, work in different ways to stop tumor cells from dividing so they stop growing or die. Estrogen can stimulate the growth of tumor cells. Hormone therapy using tamoxifen may fight cancer by blocking the uptake of estrogen. Combining tamoxifen with chemotherapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving cisplatin and doxorubicin together with tamoxifen works in treating patients with solid tumors.

Timeline

Start
1994-05
Primary completion
Completion
2005-04

Publications

  • Results Gertler SZ, Yau J, Stewart DJ, et al.: Cisplatin, doxorubicin and tamoxifen (CAT) in the treatment of incurable soft tissue and endocrine malignancies-preliminary results. [Abstract] Proceedings of the American Society of Clinical Oncology 15: A1427, 1996.

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified Intravenous
Subject Doxorubicin Other / unclassified Intravenous
Subject Tamoxifen Small molecule Oral